GlassScriptPhysician profile
William B Steinkohl
NPI 1689769440
$1,130.23
in general payments reported to CMS, 2019-2025
13 companies · $51.20 in 2025
The $51.20 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $70.75 · 2021: $46.85 · 2022: $233 · 2023: $206 · 2024: $60.25 · 2025: $51.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.35 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $376.15 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $177.89 | 2019-2020 | |
| Procept Biorobotics Corporation | $159.16 | 2022 | |
| Allergan, INC. | $116.55 | 2019 | |
| 180 Medical, INC. | $86.81 | 2019-2025 | |
| Urogen Pharma, INC. | $68.29 | 2022-2023 | Jelmyto |
| Olympus America INC. | $36.84 | 2024 | Itind System |
| Sumitomo Pharma America, INC. | $24.47 | 2023 | Gemtesa |
| Laborie Medical Technologies Corp. | $23.41 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $22.86 | 2022 | |
| Coloplast Corp | $14.06 | 2019 | |
| Dendreon Pharmaceuticals LLC | $12.07 | 2021 | |
| Axonics, INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Steinkohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.